Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol of Clinical Trial of EAFO 2012: Adjuvant Therapy of Skin Melanoma With Use of Alpha Interferon and Naderin

NCT07671495 is registered in ClinicalTrials.gov with MIPO Clinic as lead sponsor.

NCT NCT07671495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol of Clinical Trial of EAFO 2012: Adjuvant Therapy of Skin Melanoma With Use of Alpha Interferon and Naderin
Lead sponsor
MIPO Clinic
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2018
Enrollment
278 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma stage i, melanoma stage ii, melanoma stage iii, skin melanoma